Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1999 1
2000 1
2005 1
2015 1
2016 1
2020 1
2021 2
2022 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
SEOM-GEM clinical guidelines for cutaneous melanoma (2023).
Márquez-Rodas I, Muñoz Couselo E, Rodríguez Moreno JF, Arance Fernández AM, Berciano Guerrero MÁ, Campos Balea B, de la Cruz Merino L, Espinosa Arranz E, García Castaño A, Berrocal Jaime A. Márquez-Rodas I, et al. Among authors: berrocal jaime a. Clin Transl Oncol. 2024 May 15. doi: 10.1007/s12094-024-03497-2. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38748192
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
SEOM-GEINO clinical guideline of systemic therapy and management of brain central nervous system metastases (2021).
Martínez-García M, Servitja Tormo S, Vilariño Quintela N, Arance Fernández A, Berrocal Jaime A, Cantos Sánchez de Ibargüen B, Del Barco Berrón S, García Campelo R, Gironés Sarrió R, Manuel Sepúlveda-Sánchez J. Martínez-García M, et al. Among authors: berrocal jaime a. Clin Transl Oncol. 2022 Apr;24(4):703-711. doi: 10.1007/s12094-022-02803-0. Epub 2022 Mar 8. Clin Transl Oncol. 2022. PMID: 35258806 Free PMC article.
[Euthanasia in patients with cancer and the continuous-care providers].
Camps Herrero C, Gavilá Gregori J, Garde Noguera J, Caballero Díaz C, Iranzo González-Cruz V, Juárez Marroquí A, Safont Aguilera MJ, Blasco Cordellat A, Berrocal Jaime A, Sanz de Bremond MG. Camps Herrero C, et al. Among authors: berrocal jaime a. Clin Transl Oncol. 2005 Aug;7(7):278-84. doi: 10.1007/BF02710266. Clin Transl Oncol. 2005. PMID: 16185589 Review. Spanish.
Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.
Márquez-Rodas I, Martín González M, Nagore E, Gómez-Fernández C, Avilés-Izquierdo JA, Maldonado-Seral C, Soriano V, Majem-Tarruella M, Palomar V, Maseda R, Martín-Carnicero A, Puertolas T, Godoy E, Cerezuela P, Ochoa de Olza M, Campos B, Perez-Ruiz E, Soria A, Gil-Arnaiz I, Gonzalez-Cao M, Galvez E, Arance A, Belon J, de la Cruz-Merino L, Martín-Algarra S; Spanish Multidisciplinary Group of Melanoma (GEM). Márquez-Rodas I, et al. PLoS One. 2015 Apr 13;10(4):e0124239. doi: 10.1371/journal.pone.0124239. eCollection 2015. PLoS One. 2015. PMID: 25874698 Free PMC article.
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402).
Piulats JM, Espinosa E, de la Cruz Merino L, Varela M, Alonso Carrión L, Martín-Algarra S, López Castro R, Curiel T, Rodríguez-Abreu D, Redrado M, Gomà M, Rullán AJ, Calvo González A, Berrocal-Jaime A. Piulats JM, et al. Among authors: berrocal jaime a. J Clin Oncol. 2021 Feb 20;39(6):586-598. doi: 10.1200/JCO.20.00550. Epub 2021 Jan 8. J Clin Oncol. 2021. PMID: 33417511 Clinical Trial.
Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy.
Martínez Leboráns L, Esteve Martínez A, Victoria Martínez AM, Alegre de Miquel V, Berrocal Jaime A. Martínez Leboráns L, et al. Among authors: berrocal jaime a. Dermatol Ther. 2016 Sep;29(5):306-308. doi: 10.1111/dth.12380. Epub 2016 Jun 30. Dermatol Ther. 2016. PMID: 27357143 No abstract available.
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Hitt R, Iglesias L, López-Pousa A, Berrocal-Jaime A, Grau JJ, García-Girón C, Martínez-Trufero J, Guix M, Lambea-Sorrosal J, Del Barco-Morillo E, León-Vintró X, Cunquero-Tomas AJ, Baste N, Ocaña A, Cruz-Hernández JJ; the Spanish Head and Neck Cancer Cooperative Group (TTCC). Hitt R, et al. Among authors: berrocal jaime a. Clin Transl Oncol. 2021 Apr;23(4):764-772. doi: 10.1007/s12094-020-02467-8. Epub 2020 Aug 14. Clin Transl Oncol. 2021. PMID: 32797376
[Hematopoietic growth factors and anaphylaxis].
Balaguer AA, Berrocal Jaime A, Noguerón Martínez E, Camps Herrero C. Balaguer AA, et al. Among authors: berrocal jaime a. Med Clin (Barc). 1999 May 1;112(15):598. Med Clin (Barc). 1999. PMID: 10365392 Spanish. No abstract available.
11 results